Guo Xueyuan, Li Ling, Jia Wenhua, Zhang Chen, Ren Wei, Liu Chenghui, Tang Yanli
Key Laboratory of Analytical Chemistry for Life Science of Shaanxi Province, Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education, School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an 710119, P. R. China.
ACS Appl Mater Interfaces. 2023 Nov 17. doi: 10.1021/acsami.3c12553.
Phototherapies such as photodynamic therapy (PDT) and photothermal therapy (PTT) have attracted great attention in the field of cancer treatment. However, the individual PDT or PTT makes it difficult to achieve optimal antitumor effects compared to the PDT/PTT combined therapy. Also, the effect of PDT is usually limited by the penetration depth of the UV-vis light source. Herein, we designed and synthesized novel composite nanoparticles UCNPs-CPs, which are constructed from two conjugated polymers and upconversion nanoparticles β-NaYF4:Yb,Tm (UCNPs) via a coordination reaction. By virtue of the excellent spectral overlap between absorption of conjugated polymers and emission of UCNPs, the UCNPs can absorb NIR light and effectively excite conjugated polymers by energy transfer to produce massive reactive oxygen species under 980 nm excitation and heat energy under 808 nm laser irradiation, achieving photodynamic/photothermal synergistic therapy. The in vitro cellular investigation proves that the dual modal phototherapy exhibits enhanced antitumor ability compared to single PDT or PTT. Furthermore, UCNPs-CPs inhibit tumor growth 100% in a 4T1 breast tumor mice model with both NIR laser irradiation, indicating that UCNPs-CPs is an excellent platform for synergistic PDT/PTT treatment. Thus, this study provides a promising strategy for NIR-triggered dual modal phototherapy.
诸如光动力疗法(PDT)和光热疗法(PTT)等光疗法在癌症治疗领域引起了极大关注。然而,与PDT/PTT联合疗法相比,单独的PDT或PTT难以实现最佳抗肿瘤效果。此外,PDT的效果通常受紫外-可见光光源穿透深度的限制。在此,我们设计并合成了新型复合纳米粒子UCNPs-CPs,它是由两种共轭聚合物和上转换纳米粒子β-NaYF4:Yb,Tm(UCNPs)通过配位反应构建而成。凭借共轭聚合物吸收与UCNPs发射之间出色的光谱重叠,UCNPs能够吸收近红外光,并通过能量转移有效激发共轭聚合物,从而在980 nm激发下产生大量活性氧物种,在808 nm激光照射下产生热能,实现光动力/光热协同治疗。体外细胞研究证明,与单一的PDT或PTT相比,这种双模态光疗法具有更强的抗肿瘤能力。此外,在近红外激光照射下,UCNPs-CPs在4T1乳腺肿瘤小鼠模型中100%抑制肿瘤生长,表明UCNPs-CPs是用于协同PDT/PTT治疗的优秀平台。因此,本研究为近红外触发的双模态光疗法提供了一种有前景的策略。
Front Immunol. 2024
Int J Mol Sci. 2024-4-9